301 related articles for article (PubMed ID: 23095751)
1. The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.
de la Parra C; Otero-Franqui E; Martinez-Montemayor M; Dharmawardhane S
J Biol Chem; 2012 Dec; 287(50):41640-50. PubMed ID: 23095751
[TBL] [Abstract][Full Text] [Related]
2. Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.
de la Parra C; Borrero-Garcia LD; Cruz-Collazo A; Schneider RJ; Dharmawardhane S
J Biol Chem; 2015 Mar; 290(10):6047-57. PubMed ID: 25593313
[TBL] [Abstract][Full Text] [Related]
3. Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.
Koo J; Cabarcas-Petroski S; Petrie JL; Diette N; White RJ; Schramm L
BMC Cancer; 2015 Nov; 15():905. PubMed ID: 26573593
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
[TBL] [Abstract][Full Text] [Related]
5. The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.
Rigalli JP; Scholz PN; Tocchetti GN; Ruiz ML; Weiss J
Eur J Nutr; 2019 Feb; 58(1):139-150. PubMed ID: 29101532
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
Ju YH; Fultz J; Allred KF; Doerge DR; Helferich WG
Carcinogenesis; 2006 Apr; 27(4):856-63. PubMed ID: 16399773
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
[TBL] [Abstract][Full Text] [Related]
8. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
9. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
10. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.
Martínez-Montemayor MM; Otero-Franqui E; Martinez J; De La Mota-Peynado A; Cubano LA; Dharmawardhane S
Clin Exp Metastasis; 2010 Oct; 27(7):465-80. PubMed ID: 20517637
[TBL] [Abstract][Full Text] [Related]
11. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G.
Ali IK; McKendrick L; Morley SJ; Jackson RJ
J Virol; 2001 Sep; 75(17):7854-63. PubMed ID: 11483729
[TBL] [Abstract][Full Text] [Related]
12. Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2.
Magee PJ; Allsopp P; Samaletdin A; Rowland IR
Eur J Nutr; 2014 Feb; 53(1):345-50. PubMed ID: 23568763
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element.
Froyen EB; Steinberg FM
J Nutr Biochem; 2011 Sep; 22(9):843-8. PubMed ID: 21167702
[TBL] [Abstract][Full Text] [Related]
14. Binding of eukaryotic translation initiation factor 4E (eIF4E) to eIF4G represses translation of uncapped mRNA.
Tarun SZ; Sachs AB
Mol Cell Biol; 1997 Dec; 17(12):6876-86. PubMed ID: 9372919
[TBL] [Abstract][Full Text] [Related]
15. 5'-Cap‒Dependent Translation as a Potent Therapeutic Target for Lethal Human Squamous Cell Carcinoma.
Srivastava RK; Khan J; Arumugam A; Muzaffar S; Guroji P; Gorbatyuk MS; Elmets CA; Slominski AT; Mukhtar MS; Athar M
J Invest Dermatol; 2021 Apr; 141(4):742-753.e10. PubMed ID: 32971126
[TBL] [Abstract][Full Text] [Related]
16. Cellular cap-binding protein, eIF4E, promotes picornavirus genome restructuring and translation.
Avanzino BC; Fuchs G; Fraser CS
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9611-9616. PubMed ID: 28827335
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E.
Ohlmann T; Rau M; Pain VM; Morley SJ
EMBO J; 1996 Mar; 15(6):1371-82. PubMed ID: 8635470
[TBL] [Abstract][Full Text] [Related]
18. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
Mathey J; Mardon J; Fokialakis N; Puel C; Kati-Coulibaly S; Mitakou S; Bennetau-Pelissero C; Lamothe V; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
Osteoporos Int; 2007 May; 18(5):671-9. PubMed ID: 17333448
[TBL] [Abstract][Full Text] [Related]
19. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI
Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169
[TBL] [Abstract][Full Text] [Related]
20. Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E.
Gross JD; Moerke NJ; von der Haar T; Lugovskoy AA; Sachs AB; McCarthy JE; Wagner G
Cell; 2003 Dec; 115(6):739-50. PubMed ID: 14675538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
